The New York City-based company has created a massive directory of healthcare providers to help biotech companies connect with them for clinical trials and educate them about new treatments.
“We see a critical need for H1’s global healthcare network, especially when it comes to improving diversity in clinical trials and improving healthcare equity,” Chase Williams of funder Goldman Sachs said in a June 9 H1 news release.
The startup is valued at $773 million. Other funders have included Altimeter Capital and Menlo Ventures.
“In a time of volatile markets when many are struggling to secure funding, this extension is a vote of confidence in our ability to advance our mission,” H1 co-founder and CEO Ariel Katz said. “Our platform has enabled our 200-plus clients to gain greater insights and get groundbreaking treatments and therapies to patients around the world efficiently.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
